Leads Patients Prescription Transportation 
Pharmaceutical Technology
SEPTEMBER 7, 2022
Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. Pharmacies can cater to the needs of individuals with both complex and relatively simple medical conditions, while some also provide customised and highly personalised care to patients with chronic medical conditions. Speciality care.
pharmaphorum
DECEMBER 18, 2022
Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. We believe that innovation in patient access models is the necessary catalyst to aid patients in starting on and staying on the therapies they need to improve their lives.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MARCH 3, 2023
Albireo’s pipeline includes its lead asset, Bylvay (odevixibat), a potent, once-a-day, oral, non-systemic, ileal bile acid transport inhibitor (IBATi). In 2021, it secured regulatory approvals in the US to treat pruritus in progressive familial intrahepatic cholestasis (PFIC) in patients aged three months and above.
PM360
SEPTEMBER 15, 2022
The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?
Clarify Health
JANUARY 26, 2022
It is a real-world evidence-based software product that empowers life sciences companies to improve the recruitment of diverse and underrepresented patient populations. These data are linked to government and commercial claims, clinical, prescription and dispensing data, covering over 300 million patient lives.
PM360
JULY 13, 2023
PM360 asked experts in helping patients stay on their prescribed therapies about where the industry could make the biggest improvements and how to better detect potential barriers. How can the industry better monitor and detect potential barriers to adherence for individual patients? How can they improve?
PM360
JULY 13, 2023
If one of those conditions is type 2 diabetes, that person may be taking seven prescription medications, 1 managing two or more additional chronic conditions, 2 and paying $13,000 per year on healthcare. senior adults (aged 65+) 7 taking five or more prescription medications. 3 They are also 2.6 In the U.S., 5 This links to 22% of U.S.
Expert insights. Personalized for you.
59 
Let's personalize your content